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Proper timely management of various external and internal stresses is critical
for metabolic and redox homeostasis in mammals. In particular, dysregulation of
mechanistic target of rapamycin complex (mTORC) triggered from metabolic stress
and accumulation of reactive oxygen species (ROS) generated from environmental and
genotoxic stress are well-known culprits leading to chronic metabolic disease conditions
in humans. Sestrins are one of the metabolic and environmental stress-responsive
groups of proteins, which solely have the ability to regulate both mTORC activity and
ROS levels in cells, tissues and organs. While Sestrins are originally reported as one
of several p53 target genes, recent studies have further delineated the roles of this
group of stress-sensing proteins in the regulation of insulin sensitivity, glucose and
fat metabolism, and redox-function in metabolic disease and aging. In this review,
we discuss recent studies that investigated and manipulated Sestrins-mediated stress
signaling pathways in metabolic and environmental health. Sestrins as an emerging
dynamic group of stress-sensor proteins are drawing a spotlight as a preventive or
therapeutic mechanism in both metabolic stress-associated pathologies and aging
processes at the same time.
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INTRODUCTION OF SESTRINs
SESTRINs (Sestrin1, 2, and 3, gene name: Sesn) are a classical family of stress-inducible proteins
that regulate metabolism through sensing nutrient level and redox status in cells, tissues and
organs. Sesn1 (aka PA26) was originally identified as one of the p53 tumor suppressor target
genes in a tetracycline-dependent manner (Buckbinder et al., 1994) and located in chromosome
6q21 (Velasco-Miguel et al., 1999). Sesn1 is also largely expressed ubiquitously in almost all
tissues including the pancreas, kidney, skeletal muscle, lung, and brain (Budanov et al., 2002) and
activated in a p53-dependent manner under oxidative and irradiation stresses (Sablina et al., 2005;
Budanov and Karin, 2008). Sesn2 (aka Hi95) was identified by microarray in Hif1-independent
hypoxia condition of glioblastoma A172 cells and located in chromosome 1p35.3 (Budanov et al.,
2002). Sesn2 is activated by DNA damaging oxidative stress and overnutrition stress in the lung,
liver, adipose, kidney and pancreas (Budanov et al., 2002; Lee et al., 2012). Sesn3 was originally
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identified by in silico data base search and located in chromosome
11q21 (Budanov et al., 2002; Peeters et al., 2003). Sesn3 is
activated by FoxO1 and 3 (Nogueira et al., 2008; Chen et al.,
2010; Hagenbuchner et al., 2012) and overexpressed in skeletal
muscle, intestine, liver, adipose, kidney, colon and brain (Peeters
et al., 2003). However, Sesn3 is somewhat redundant to Sesn2 in
metabolic function and autophagy induction in liver and colon
tissues (Lee et al., 2012; Ro et al., 2016). Although ectopically
expressed Sestrin2 protein is mostly found in cytoplasm
(Parmigiani et al., 2014), recent studies suggest that Sestrin2 is
associated with mitochondria (Kim H. et al., 2020; Kovaleva et al.,
2020), nucleus (Tu et al., 2018; Wang L.X. et al., 2020), and
endoplasmic reticulum (ER) (Wang L.X. et al., 2020) depending
on intra- or extra- cellular stress conditions. Those three Sestrin
paralogues have a common antioxidant function that suppresses
reactive oxygen species (ROS) (Lee et al., 2013; Wang et al.,
2017). Another shared function is that Sestrins activate AMP-
activated protein kinase (AMPK), inhibiting the mechanistic
target of rapamycin complex 1 (mTORC1) (Parmigiani and
Budanov, 2016). Upregulation of mTORC1 has been shown
to lead to the accelerated development of several obesity-
induced and age-related pathologies, such as lipid accumulation,
inflammation, glucose tolerance, insulin resistance, ER stress,
mitochondrial dysfunction, protein aggregate formation, cardiac
arrhythmia and muscle degeneration (Um et al., 2006; Zoncu
et al., 2011). Sestrins are considered to improve obesity-induced
and age-related pathologies by inhibiting mTORC1. Protein
kinase B (AKT) activation through mTORC2 activation by
Sestrins leads to improved insulin sensitivity in obesity and
diabetes (Dong, 2015; Kazyken et al., 2019; Knudsen et al., 2020).
These pathologies were remedied by inhibition of mTORC1,
activation of mTORC2/AKT and the use of antioxidants, which
shows that the mTORC- and ROS-controlling functions of
Sestrins are indeed important for metabolism and cellular
homeostasis (Figure 1A).
By sensing nutrient and redox-activity levels, Sestrins can
integrate cellular signal transduction through their conserved
residues and translational and transcriptional modifications
(Figure 1B). Recent studies of the X-ray crystal structure of
Sestrin2 show that it belongs to the family of globin-like α-
helix-fold proteins, consisting of 23 helices and no β-sheets,
structured by well-conserved Sesn-A [AA 66–239, N-terminal
structuring domain (NTD)], Sesn-B [AA 254–294, loop linker
domain] and Sesn-C [AA308-480, C-terminal domain (CTD)]
domains among species. Sesn-A and Sesn-C structure are very
similar but they have distinctive functions. Sesn-A and Sesn-
C are connected by flexible loop linker domain Sesn-B whose
functions are not yet known (Kim H. et al., 2015; Ho et al., 2016;
Saxton et al., 2016b). Sesn-A has an evolutionarily conserved
Cys125 residue with a thiol side chain that has antioxidant
function through reducing ROS accumulation (Budanov et al.,
2004; Ro et al., 2014a; Kim H. et al., 2015). Knowing the unique
structural features of human Sestrin2, several genetic variations
and protein modification studies reported the dynamic roles
of Sesn2 in nutrient-sensing, redox-active function, and signal
transduction in relation to disease status. K13 and K48 of Sesn-A
are ubiquitinated by E3 ligase ring finger protein 186 (RNF186)
and ring-box protein 1 (RBX-1) respectively, causing Sestrin2’s
degradation in the proteasome (Kumar and Shaha, 2018a; Lear
et al., 2019). Using a high-throughput whole-genome single-
cell sequencing, Hou et al. (2012) reported that P87S missense
mutation of Sesn2 was found in patients with a certain type
of blood cancer, myeloproliferative neoplasms (MPNs), causing
aggressive progression of neoplasms. Interestingly, several
phosphorylation sites are identified and regulated by unc-51 like
autophagy activating kinase 1 (ULK1). ULK1 phosphorylates
T232/S249/S279 residues of Sestrin2 which inhibits Sestrin2’s
binding with leucine in high nutrient condition (Kimball et al.,
2016). Exercise increases the same phosphorylation profile of
Sestrin2 and improves skeletal muscle metabolism (Zeng et al.,
2017, 2018b). ULK1 also phosphorylates S73 and S254 to activate
the autophagic clearance of mitochondria in response to copper-
induced oxidative stress (Kim H. et al., 2020). L261 and E451
are identified as essential residues for leucine binding in HEK293
cells (Lee et al., 2016; Saxton et al., 2016a,b; Wolfson et al., 2016).
DD406/7 are identified as key residues for GTPase-activating
protein (GAP) activity toward recombination activating genes
(RAGs) (GATOR) 2 binding so that Sestrin2 can inhibit mTORC1
association with lysosome for its activation (Kim H. et al.,
2015; Ho et al., 2016). LSD1, upon deacetylation by histone
deacetylase 1 (HDAC1), reduced the methylations of H3K4me2
in the promoter region of Sesn2, thereby suppressed the gene
expression of Sesn2 in chronic renal failure (CRF) (Zhou
et al., 2020). Jumonji domain-containing protein D3 (JMJD3),
a histone demethylase, inhibited the transcription of Sesn2 by
reducing the methylations of H3K27me3 in the promoter region
of Sesn2 in cardiomyopathy (Wang P. et al., 2020). Although
dense methylation of CpG islands of Sesn3 was identified in
20% of endometrial cancers (Zighelboim et al., 2007), the
transcriptional regulation (e.g., methylation and demethylation)
of Sesn genes needs further investigation (Ambrosio et al., 2019).
Knowing that Sestrin2 stability, redox-active function, nutrient
sensing, and interaction with other proteins can be regulated
through those identified residues (Figure 1B), the development
of methodology measuring the activity of specific Sestrin2
functional residues would be a promising venue combating
against stress-induced pathologies.
Metabolic dysregulation induces Sestrins as a defense
mechanism against obesity and metabolic diseases (Lee et al.,
2012; Parmigiani and Budanov, 2016; Dalina et al., 2018).
Important key features of cellular function are the regulation
of insulin sensitivity, lipid/fatty acid (FA) metabolism, ER
stress, and autophagy (Lee et al., 2012, 2020; Park et al., 2014).
Glucose starvation, ER stress, amino acid deprivation and
mitochondrial dysfunction induces Sestrins as a protective
mechanism (Park et al., 2014; Ro et al., 2015; Ye et al., 2015;
Ding et al., 2016; Garaeva et al., 2016; Saveljeva et al., 2016).
Sestrins are central nutrient status sensors and regulates AMPK,
mTORC and subsequent downstream metabolic pathways.
Sestrin2 improves insulin sensitivity, prevents excessive
lipid accumulation and alleviates ER stress by inhibiting
mTORC1 through AMPK activation (Budanov and Karin,
2008) and GATOR binding (Chantranupong et al., 2014;
Parmigiani et al., 2014; Kim J.S. et al., 2015) (Figure 1A).
Frontiers in Cell and Developmental Biology | www.frontiersin.org 2 December 2020 | Volume 8 | Article 603421
fcell-08-603421 November 28, 2020 Time: 17:57 # 3
Ro et al. SESTRINs: Stress-Sensors
FIGURE 1 | Diagrams depicting the Sestrins-mediated stress signaling pathways and functional domains of Sestrin2 in the regulation of metabolism and disease.
(A) Schematic diagram of Sestrins/mTORC/ROS pathways in obesity and metabolic diseases induced by metabolic dysregulation stress. Sestrins improve insulin
sensitivity by blocking mTORC1/ribosomal protein S6 kinase 1(S6K1) and activating AMPK and mTORC1/AKT pathway. Sestrins also inhibit lipid accumulation and
ER stress via mTORC1 inhibition through activating AMPK and binding GATOR2. Sestrins activate autophagy and mitophagy through mTORC1 inhibition and ULK1
activation, which contributes to reducing ROS and removing dysfunctional mitochondria. ULK1 phosphorylates Sestrin2 to induce mitophagy, and phosphorylated
Sestrin2 activates ULK1 to further induce autophagy as positive feedback mechanism. Sestrins protect cells, tissues and organs by alleviating stresses and
pathologies associated with obesity and metabolic dysfunctions. (B) Sestrin2 functional domains (Sesn-A, Sesn-B, and Sesn-C domains) and residues for: (i) protein
stability and turnover through ubiquitinations by RNF186 and RBX-1; (ii) redox homeostasis through ROS regulation (Cys125); and (iii) nutrient sensing and regulation
through leucine binding, ULK1 activation, and autophagy induction.
Tao et al. (2015) reported that Sestrin3 prevents insulin
resistance by activating mTORC2/AKT pathways in the liver.
Sestrin2 also activates AKT through mTORC2 and GATOR2
(MIOS/WDR24/SEH1L/WDR59/SEC13) bindings (Kowalsky
et al., 2020). Sestrins can eliminate ROS by inducing antioxidants
enzymes by activating nuclear factor erythroid 2-related factor
2 (Nrf2) through p62 (gene name: SQSTM1)-dependent
degradation of Kelch-like ECH-associated protein 1 (Keap1)
pathways, which can reduce the damaged mitochondria,
improve fat metabolism, and maintain mitochondrial function
in mammalian cells (Bae et al., 2013). Knockdown of Sestrin2
aggravates the atherosclerotic process in human umbilical
vein endothelial and THP-1 cell lines and C57BL/6 mice by
increasing pro-inflammatory response (Hwang et al., 2017).
Sestrin2 suppresses sepsis by inhibiting prolonged nod-like
receptor (NLR) family pyrin domain containing 3 (NLRP3)-
inflammasome activation (Kim et al., 2016) and protects
macrophage by inhibiting TLR-induced pro-inflammatory
signaling (Yang et al., 2015). Lysine-specific demethylase 1
(LSD1) suppresses oxidized low-density lipoprotein (Ox-
LDL)-induced inflammation by promoting Sestrin2-mediated
PI3K/AKT/mTOR pathway activation (Zhuo et al., 2019).
Recently, Navitor Pharmaceuticals developed Sestrin2-specific
inhibitor, a leucine analog NV-5138, and try to treat the major
depressive disorder (MDD) by activating mTORC1 in the brain
(Hasegawa et al., 2019; Kato et al., 2019; Sengupta et al., 2019).
However, one of the main causes of obesity, inflammation and
metabolic disease is the hyperactivation of mTORC1, so the
development of Sestrin2-specific activator compound or drug
would be a potential therapeutic (Dong, 2015). Indeed, several
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recent studies suggest that synthetic chemicals or naturally
occurring compounds induces Sestrins gene expression as
adaptive defense mechanisms upon various cellular damaging
stresses (Sanchez-Alvarez et al., 2019). In the examples of
Sesn2 induction, synthetic drugs such as eupatilin (Jegal et al.,
2016), topotecan (TPT) (Chen et al., 2015), tanshinone IIA
(TIIA) (Yen et al., 2018), and cheliensisin A (ChlA)-F (Hua
et al., 2018) induce autophagy by increasing Sesn2 expression
as cellular defense upon oxidative stress and DNA damage.
The naturally occurring resveratrol inhibits hepatic lipogenesis
through Sesn2 induction (Jin et al., 2013), thus keeping fatty
liver in check. Nelfinavir/bortezomib (Bruning et al., 2013)
and protopanaxadiol (PPD) (Jin et al., 2019) are known to
induce Sesn2 through protein kinase R (PKR)-like endoplasmic
reticulum kinase (PERK)/ cyclic AMP-dependent transcriptional
factor (ATF) 4 activation upon ER stress. Albeit the increasing
therapeutic potential of allosteric modulation of Sestrin2 is
promising, the unexpected side effects should be thoroughly




In modern westernized society, excessive consumption of
fat and sugar combined with sedentary life style causes an
exponential increase in the number of patients with obesity and
metabolic diseases such as diabetes, cardiovascular disease, and
cancer (Bidwell, 2017; Pallazola et al., 2019; Leisegang et al.,
2020). Hyperactivation of mTORC1 is one of the underlying
mechanisms causing insulin resistance, lipid accumulation,
ER stress, defective autophagy function and mitochondrial
dysfunction (Um et al., 2006; Zoncu et al., 2011; Tao and Xu,
2020). Here, we reviewed Sestrins, potent inhibitors of mTORC1,
and its mechanism for preventing nutrient-associated stress and
metabolic dysfunctions.
After Sesn1 was originally identified as one of the p53 target
genes in the late 90’s (Velasco-Miguel et al., 1999), Sesn2 was also
identified under the control of p53 to induce autophagy under
DNA damage and oxidative stress (Maiuri et al., 2009). When S18
of p53, a phosphorylated target of ataxia-telangiectasia mutated
(ATM) kinase, was mutated to Ala in p53 S18A knock-in mice,
these mice developed a diabetic phenotype with abnormal glucose
homeostasis and insulin resistance within 6 months of age. This
phenotype was alleviated with ectopically overexpressed Sestrin2,
suggesting that Sestrin2 has an anti-diabetic effect (Armata et al.,
2010). Indeed, Sestrin2 and 3 have a protective effect against
obesity-induced metabolic dysfunction and insulin resistance,
which is revealed by investigating the liver and adipose tissues
of Sesn2/3 double knockout (DKO) mice (Lee et al., 2012). Sesn2
ablation exacerbates obesity-induced mTORC1-S6K activation,
and moreover, the concomitant ablation of Sesn2 and Sesn3
provokes hepatic mTORC1-S6K activation and insulin resistance
even in the absence of nutritional overload and obesity (Lee et al.,
2012). Although Sesn2 is suggested to be dominant over Sesn3 in
the previous adipose and liver metabolism studies, each Sestrin
have unique stress-specific regulatory functions. Sestrin2-AMPK
axis alleviates hyperglycemia-induced glomerular injury caused
by high glucose, high level of ROS and decreased level of nitric
oxide (Eid et al., 2013). Sestrin3 reduces lipid accumulation of
chronic alcohol-induced liver injury (Kang et al., 2014). And this
demonstrates an important homeostatic function for the stress-
inducible Sestrin protein family in the control of mammalian
lipid and glucose metabolism. It is shown that Sesn3 liver-specific
knockout (KO) mice exhibit insulin resistance and glucose
intolerance, and Sesn3 transgenic mice were protected against
insulin resistance induced by a high fat diet (HFD). Also, it
has been demonstrated that the Sesn3 insulin-sensitizing effect
is largely independent of AMPK, and Sesn3 can activate AKT
via mTORC2 to regulate hepatic insulin sensitivity and glucose
metabolism (Tao et al., 2014). However, the study using adipose-
specific Sestrin2 overexpressing mice (PG-Sesn2) suggests that
Sestrin2 interferes with brown adipose tissue (BAT)-specific
expression of uncoupling protein 1 (UCP1) through suppression
of ROS-mediated p38 MAPK activation, and resulted in the
undesirable accumulation of lipids in BAT (Ro et al., 2014a).
These results indicate that maintaining the physiological level
and activity of Sestrins in each tissues are critical for metabolic
homeostasis and may provide a new therapeutic approach for the
prevention of obesity, insulin resistance and diabetes.
Regular physical exercises benefit human health by
protecting humans against obesity and metabolic dysfunctions
including insulin resistance, glucose intolerance and galactose
malabsorption. However, the mechanism of how Sestrins are
induced by exercise and their beneficial effects on human
health are not completely understood (Nascimento et al., 2013).
AMPK and TORC1 are cellular energy sensors that respond
in a reciprocal manner to environmental conditions such as
nutrient supply or cellular stress to control metabolism and
growth in insulin-sensitive tissues like skeletal muscle. A recent
study suggests that exercise induces direct interaction between
Sestrin2 and AMPK and improves insulin sensitivity through
autophagy induction (Li et al., 2017). The expression levels of
both Sestrin2 and 3 along with autophagy activity were increased
in skeletal muscle of HFD-fed mice after long-term physical
exercises (Liu et al., 2015). Both Sestrin2 and 3 directly bind with
AMPK and promotes glucose uptake in skeletal muscle in wild
type (C57BL/6) and but not in AMPKα2−/− mice (Morrison
et al., 2015; Wang et al., 2018). Sestrins were directly induced by
exercise and its phosphorylation by ULK1 kinase was observed
along with autophagy induction which improved metabolic
parameters, prevented atrophy and maintained mitochondrial
mass in muscle (Li et al., 2019; Xu et al., 2019; Kim M. et al., 2020;
Segales et al., 2020). Acute exercise increased Sestrin1 whereas
chronic exercise up to 4 weeks increased both Sestrin1 and 2
in mice suggesting that Sestrins have distinct functions on the
intensity and duration of the exercise (Crisol et al., 2018). In these
studies, Sestrins were suggested as plausible cellular mechanism
by which exercise protects against metabolic diseases.
Chronic hyperactivation of mTORC1 is one of the hallmarks
of tumor proliferation and growth as cancer cells rapidly
synthesize proteins, lipids and cellular components in
response to metabolic dysregulation, hypoxic environment
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and genetic mutation stresses (Guertin and Sabatini, 2007; Jones
and Thompson, 2009). mTORC1-specific inhibitors such as
rapamycin, metformin and aspirin suppresses intestinal and
breast cancer initiation and growth (Faller et al., 2015; Pulito
et al., 2017). mTORC1/2 inhibitor torin suppresses hepatocellular
carcinoma (HCC) cell growth (Wang et al., 2015). Although
mTOR inhibitors were widely used previously, efficacy and
safety on cancer patients are controversial due to their side
effects (Kalender et al., 2010; Blagosklonny, 2011; Din et al.,
2012). Knowing that Sestrins are specific mTORC1 inhibitors
through AMPK activation and GATOR binding, Sestrin-based
therapeutics are emerging as a novel anti-cancer and tumor
treatment with less off-target effects. Here, we have reviewed
how Sestrins act on tumor suppression and progression in two
different aspects. Recent studies identified that Sestrin2 is down-
regulated in colorectal cancer and overexpression of Sestrin2
inhibited colon carcinogenesis through mTORC1 inhibition
(Wei J.L. et al., 2015; Wei et al., 2017; Ro et al., 2016). Loss of
heterozygosity in Sesn1 (6q21) and Sesn2 (1p35) is frequently
detected in human solid tumors (Ragnarsson et al., 1999;
Velasco-Miguel et al., 1999). Sestrins are targets of p53 which,
under normal conditions, prevents the outgrowth of cancer cells.
There is evidence in the literature which shows that chronic
stress-induced inactivation of the p53 target, Sestrin family,
promotes the outgrowth of cancer cells. For some examples,
inactivation of p53 and repression of Sesn1/3 contribute to Ras
oncogene-induced ROS accumulation and genetic instability
in immortalized embryonic fibroblasts (Kopnin et al., 2007).
Sesn2-deficient mouse embryonic fibroblast (MEF) cells were
significantly more susceptible to oncogenic stresses (Budanov
and Karin, 2008). Sesn2 inhibition promotes A549, human
a non-small cell lung carcinoma, cell growth (Sablina et al.,
2005), and its expression level is negatively correlated with the
lung cancer survival rate (Chae et al., 2020). Sesn3 induces
apoptosis of human non-small cell lung cancer (NSCLC) cells in
dietary compound cucurbitacin B treatment (Khan et al., 2017).
Sesn3-deficiency developed severe HCC via hedgehog pathway
activation in Sesn3 KO mice (Liu et al., 2019). In the recent
study, knockdown of Sesn2 promoted the cell growth, migration,
and oxidative stress of HEC-1A and ishikawa endometrial
cancer cells through mTOC1 hyperactivation (Shin et al., 2020).
These findings suggested that Sestrins have a tumor suppressive
function through downstream activation by p53.
On the contrary to Sestrins’ tumor suppressive role, other
studies suggest that Sestrins would promote cancer cell
proliferation and growth in nutrient-deficient or oxygen- limited
(hypoxic) conditions because Sestrins can activate autophagy and
reduces ROS in the hypoxic cancer microenvironment (Maiuri
et al., 2009). Sesn2 promotes tumorigenesis and chemo-resistance
under Ultraviolet B (UVB) stress and chemo-therapeutics by
activating AKT in human squamous cell carcinomas (SCCs)
and melanoma cells (Zhao et al., 2014). Both UVB and UVA
induce Sesn2 upregulation in melanocytes and melanoma cells
suggesting the oncogenic role of Sesn2 in melanoma skin cancer
(Zhao et al., 2017). The gene expression of Sesn2 upregulated
by miR182-5p suppression in arsenic treatment functions as an
antioxidant in Uppsala 87 malignant glioma (U87MG), human
lung adenocarcinoma H1299, and A549 cell lines (Lin et al.,
2018). Sesn2 would promote colorectal cancer cell growth in the
iron-rich environment by suppressing ROS (Kim et al., 2019).
Sestrins promote anchorage-independent (anoikis resistance)
growth of human endometrial cancer cells (Kozak et al., 2019).
Despite Sestrins’ contribution on early tumor growth, Sestrins
suppress late stages of carcinogenesis in a mouse lung cancer
model and A549 cells (Ding et al., 2019). Carnosol, a dietary
diterpene from rosemary, induces Sestrins as antioxidants in
apoptotic death of HepG2 human hepatoma and HCT116 and
SW480 human colorectal carcinoma cells (Tong et al., 2017; Yan
et al., 2018). Sestrins promote cell death of breast cancer cells
upon irradiation and DNA-damaging drug treatment through
mTORC1 inhibition (Sanli et al., 2012). On the other hand,
Sestrins may block oxidative damage-associated chemotherapy
by reducing ROS (Budanov and Karin, 2008; Hagenbuchner et al.,
2012). Sestrins were upregulated upon drug treatments in various
type of pre- and mature-tumors as cell survival mechanism: head
and neck cancers (Won et al., 2019), non-alcoholic steatohepatitis
(Huang et al., 2020), HCC (Dai et al., 2018), osteosarcoma (Yen
et al., 2018), acute pancreatitis (Norberg et al., 2018), colitis (Ro
et al., 2016), bladder cancer (Hua et al., 2018), and prostate cancer
(Fu et al., 2018; Shan et al., 2019). The distinctive roles of Sestrins
as tumor suppressor or oncogene in the early or late stages of
cancers need further investigation (Sanchez-Alvarez et al., 2019).
These results might lead to a novel anti-tumor therapy through
the cancer type- and cancer stage-dependent administration or
induction of Sestrins.
SESTRINs IN ENVIRONMENTAL STRESS
AND AGING
Aging or shortening of lifespan is closely connected with the
exposure to oxidative stress, DNA damaging agents, losing
immunity, and metabolic dysregulation (Lee et al., 2013; Wei
Y. et al., 2015; Srivastava, 2017; Dalina et al., 2018; Fan et al.,
2020; Sun et al., 2020). As human life expectancy has extended,
the importance of healthy aging or elderly health is increasing
and drawing significant attention among the general public.
Since Sestrins are known to have anti-aging effect by removing
oxidative stress, improving cellular metabolism and immunity,
their therapeutic role in healthy aging and elderly health has
been emerging subject of scientific studies (Budanov et al., 2010;
Lee et al., 2010a; Budanov, 2011; Martyn and Kaneki, 2020). In
this section, we have reviewed the essential function of Sestrins
as a barometer of stress and indicator of human health at the
molecular level focusing on the recent reports.
Sestrins possess two important functions that contribute to
protecting cells, tissues and organs against environmental stress
and aging (Figure 2A). First, Sestrins function as antioxidants,
promoting regeneration of peroxiredoxins (Prxs), one of the
major ROS scavengers in cells (Budanov et al., 2004; Ro
et al., 2014a, 2015). Initially, mammalian Sestrins shows very
low similarity to any proteins performed by the basic local
alignment search tool (BLAST) search and position-specific
scoring matrix (PSSM) analysis (Budanov et al., 2004, 2010).
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FIGURE 2 | Diagrams depicting the roles of Sestrins in managing stress levels and health conditions. (A) Diagram depicting the possible roles of Sestrins in the
regulation of ROS and autophagy in mammalian cells. (Normal condition) Redox-active function of Sestrins may suppress highly reactive damaging ROS and
maintain pleiotropic ROS level such as mitohormesis in mammalian cells under normal nutrient and environmental factors. (Stress condition) Sestrins are induced by
metabolic or genotoxic stresses such as overnutrition and oxidative damage. Chronic activation of mTORC1 may induce chronic excessive ROS, which results in
aging-associated phenotypes such as fat accumulation, mitochondrial dysfunction, inflammation, and oxidative damage in mammalian cells. However, Sestrins
inhibit mTORC1 activity and subsequently induce or regulate autophagy activity in the cells and tissues. Activated autophagy removes oxidized proteins and also
clear damaged mitochondria which are producing excessive harmful ROS. Overall, Sestrins-mediated autophagy regulates the ROS level to trigger redox
adaptations under stress conditions. The underlying mechanism of how pleiotropic level of ROS is maintained by Sestrins-mediated autophagy signaling pathway
needs further investigation. (B) Graphic diagram explaining the correlation between Sestrins and stress levels in health and disease conditions.
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However, residues 100–175 AA shared sequence and structure
homology with alkyl hydroperoxidase D (AhpD) which is a
Mycobacterium tuberculosis hydrogen peroxide reductase and
regenerating oxidized bacterial Prxs AhpC by ROS or reactive
nitrogen species (RNS). AhpD is a disulfide reductase but Sestrin2
might be a cysteine sulfinyl reductase regenerating oxidized Prxs
(Budanov et al., 2004) although it remains controversial (Woo
et al., 2009). Further investigation on the role of Sestrins in
anti-oxidant defense related to Prxs which confer thiol oxidation
of a majority of cytosolic proteins including aurora kinase A
(Perkins et al., 2015; Stocker et al., 2018; Byrne et al., 2020) and
promote longevity by regulating nutrient signaling protein kinase
A (Bodvard et al., 2017; Roger et al., 2020) is warranted to resolve
this controversy. Sestrin2 reduces alkylhydroperoxide radicals
and ROS accumulation through Cys125 (Ro et al., 2014a; Kim H.
et al., 2015). Second, Sestrins stimulate autophagy by inhibiting
rapamycin-sensitive mTORC1 comprising of mTOR and Raptor
(Kim et al., 2002), through activating AMPK or through binding
with GATOR2 (Kim H. et al., 2015; Kim J.S. et al., 2015).
Inducing autophagy also contributes to the suppression of
ROS, because it eliminates dysfunctional mitochondria that
produce the pathogenic level of ROS (Salminen et al., 2012;
Ashrafi and Schwarz, 2013). Sestrins also induce the gene
expression of antioxidant enzymes via Nrf2 activation through
autophagy-mediated degradation of Keap1 (Bae et al., 2013).
Sestrin2 associates with autophagy kinase ULK1 and binds
with autophagy adaptor protein p62 to activate autophagy (Ro
et al., 2014b; Lim et al., 2015). This autophagy activity was
significantly blocked when Sesn2 KO MEF cells were treated with
rapamycin as an autophagy inducer (Lee et al., 2012). Recent
studies indicate that Sestrin2 activates the autophagic clearance of
damaged mitochondria through Parkin-ULK1-Beclin1 activation
(Kumar and Shaha, 2018b) and also induces mitophagy in
macrophages and renal tubular cells (Ishihara et al., 2013; Kim
et al., 2016). ULK1 phosphorylates Sestrin2 at S73 and S254 to
induce mitophagy upon copper-catalyzed oxidative stress (Kim
H. et al., 2020). Although recent study suggests that Sestrin2 is
colocalized with mitochondria and regulates some mitochondrial
functions (Kovaleva et al., 2020), its direct translocation into
mitochondria and involvement in maintaining mitochondrial
antioxidant enzymes function and ROS level remain unknown.
Given the existence of three distinct paralogues in
mammalian Sestrins (Sestrin1/2/3), Drosophila melanogaster
(D. melanogaster) and Caenorhabditis elegans (C. elegans)
have single Sestrin in their genomes, namely dSesn and cSesn,
respectively. Like mammalian Sestrins, dSesn is highly expressed
in cardiac and skeletal muscle tissues and fat body (Lee
et al., 2010b). dSesn-null mutant D. melanogaster significantly
exhibited multiple age-associated degenerative pathologies,
including mitochondrial dysfunction, lipid accumulation,
cardiac dysfunction, and muscle degeneration. Among these
pathologies, mitochondria dysfunction and accompanying
fat accumulation was well pronounced (Lee et al., 2010b),
which is well correlated with the muscle- and fat body-specific
expression patterns of dSesn. These pathologies were ameliorated
by administering antioxidants and/or autophagy inducers such
as metformin and rapamycin (Lee et al., 2010b). Other genetic
results also suggest that the ROS- and autophagy-regulating
functions of Sestrins are important for muscle and fat body
homeostasis in D. melanogaster (Lee et al., 2010a,b). Considering
that Sestrins are potent inducers of autophagy (Maiuri et al.,
2009) and that dSesn-deficient flies and Sesn2/3-deficient mice are
defective in autophagy function (Lee et al., 2010b, 2012; Bae et al.,
2013), it is highly speculated that Sestrins-regulated autophagy is
beneficial for metabolic tissue homeostasis and protective against
metabolic dysfunctions. dSesn reduces oxidative stress from
chromium [Cr(IV)]-induced neuronal cell death (Singh and
Chowdhuri, 2018). Recent studies also reported that C. elegans,
lack sulfiredoxin (Srx) but encode cSesn (Sesn1 orthologue),
remove oxidative stress and increase longevity (Thamsen
et al., 2011; Yang et al., 2013). Since both ROS accumulation
and autophagy inhibition are among the common molecular
pathologies underlying human metabolic dysfunctions and
aging, Sestrins may also have tissue-specific protective roles
distinctively from conserved functions in most metabolic tissues
(e.g., adipose, brain, colon, liver, cardiac muscle, and skeletal
muscle) which are very sensitive to redox regulation and aging
(Liu et al., 2015; Li et al., 2017).
Recent studies suggest that Sestrins improve longevity and
elderly health by suppressing ROS, regulating autophagy activity
and protecting metabolic dysfunction in muscle, heart and brain
(Rai et al., 2018; Chen et al., 2019; Cordani et al., 2019; Fan
et al., 2020; Liu et al., 2020; Segales et al., 2020; Sun et al.,
2020). The level of Sestrins expression is downregulated in
aged men although it has no clear correlation with autophagy
activity, mTORC1 activity and antioxidant regulation (Zeng et al.,
2018a). Both Sesn1 and 2 levels are significantly decreased in
patients with sarcopenic muscle disease (Rajan et al., 2020).
Resistant exercise but not dietary protein increased the Sesn2
level and its phosphorylation in the skeletal muscle of elderly
humans (Zeng et al., 2018b) and aged mice (Lenhare et al.,
2017). The following are examples in the way Sestrins are
involved with symptoms of aging. Sesn2 is induced in patients
with hypertension (Fang et al., 2020) and overexpressed Sesn2
was protective against cardiomyopathy (Li et al., 2019; Wang
P. et al., 2019) and cardiac dysfunction via extracellular
signal-regulated protein kinases (ERK)1/2 inhibition (Dong
B. et al., 2017) and liver kinase B (LKB)1-mediated AMPK
activation (Morrison et al., 2015). Sesn2 also prevents age-related
intolerance to myocardial infarction via AMPK/peroxisome
proliferator-activated receptor gamma coactivator 1-alpha (PGC-
1α) pathway (Quan et al., 2018), ischemia and reperfusion
injury (Quan et al., 2017), atrial fibrillation (Dong Z. et al.,
2017), radiation-induced myocardium damage (Zeng et al.,
2016) in human and rodent models. These studies indicate
that maintaining the homeostatic level of Sesn2 is protective
against cardiovascular aging (Liu et al., 2020; Sun et al.,
2020). Sesn2 promoted autophagy in the brain and prevented
neurodegenerative diseases by alleviating oxidative stress (Chen
et al., 2019; Luo et al., 2020). Sesn2 protects neuronal cells
from cerebral ischemia-reperfusion injury by increasing Nrf2,
Srx1, and thioredoxin (Trx) 1 (Zhang and Zhang, 2018).
Sesn3 positively regulates a pro-convulsant gene network in
the human epileptic hippocampus (Johnson et al., 2015).
As a non-canonical function of the Sestrin family, Sestrins
improve life-long immunity and extend longevity through
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enhancing natural killer cell function (Pereira et al., 2020) and
vaccine responsiveness (Lanna et al., 2017). Sesn3 promotes
the generation of macrophage-mediated helper T cells in colitis
(Ge et al., 2020). Taken together, Sestrins’ canonical and non-
canonical functions contribute to the protection against the aging
process and extend healthy lifespan.
PERSPECTIVE ON SESTRINs AS
STRESS SENSING-PROTEINS IN
METABOLIC DISEASE AND AGING
During the most recent decade, the research on Sestrin2 was
increased exponentially according to PubMed and google scholar
analysis data (Wang L.X. et al., 2019). Unlike other kinases or
transcription factors, a group of Sestrins protein family confers
unique dual functions: sensing nutrient stress and reducing
oxidative stress. These unique features of stress-inducible protein
Sestrins are becoming an intriguing theme among research
groups around the world. It is still debatable that maintaining
low level of ROS or RNS is actually beneficial to the human
body similar to vaccination rather than completely removing
all (Kenny et al., 2019; Klaus and Ost, 2020). For example,
mitohormesis refers to maintain physiological levels of ROS or
RNS which would benefit but could harm tissues and organs
at an excessive level (Yun and Finkel, 2014; Barcena et al.,
2018; Palmeira et al., 2019). In the current literature, ROS
is emerging as a pleiotropic physiological signaling agent in
addition to their characteristics as highly reactive damaging
species (Holmstrom and Finkel, 2014; Sies and Jones, 2020). For
instance, metformin, a well-known anti-diabetic drug, extends
the life-span of worms through the production of low levels of
mitochondrial ROS and Prxs PRDX-2 (De Haes et al., 2014).
Low levels of H2O2 extends the life-span of yeast in a Prx-
dependent manner (Goulev et al., 2017) and an endogenous
amino-acid metabolite, namely N-acetyl-L-tyrosine (NAT), was
recently shown to reduce tumor growth in mice via mitohormesis
(Matsumura et al., 2020). Sestrins could be functionally similar
to Prx by fine-tuning a pleitropic level of ROS, which might be
beneficial for human health, but the underlying mechanism needs
further interrogation. Another intriguing speculation is that
Sestrins can be induced by various stress conditions in the earlier
inflammation and metabolic dysfunction stage, then they act as
a cellular defense mechanism by suppressing mTORC1, inducing
autophagy and removing ROS. When the stress level goes over
the threshold which indicates the metabolic diseases and aging
conditions, the Sestrins level goes down in tissues and organs and
human can suffer from the irrevocable conditions confronting
pain and death (Figure 2B). Initially, the upregulation of
Sestrins is observed as a defense mechanism in the tissues under
metabolic stress and inflammation or during predisposition
stage of metabolic syndrome (Lee et al., 2012; Ro et al., 2016),
as chronic stress conditions sustain, the level of Sestrins is
dramatically suppressed in the etiology of disease conditions
such as type 2 diabetes, dyslipidemia, colon cancer development
and muscle aging progression (Wei J.L. et al., 2015; Ro et al.,
2016; Kim M. et al., 2020; Segales et al., 2020; Sundararajan
et al., 2020). In recent human studies, secreted Sestrin2 level in
the serum of obese children, diabetic nephropathy patients, and
elderly sarcopenia adults is significantly lower and associated with
metabolic dysfunction (Nourbakhsh et al., 2017; Mohany and Al
Rugaie, 2020; Rajan et al., 2020), suggesting that the expression
or the secretion of Sestrin2 is somehow blocked in the disease
state. Measuring tissue- or individual patient-specific Sestrins
level could be used as a direct health or stress sensors, and proper
timely administration of active Sestrins would be emerging
preventive or therapeutic methods for those who are suffering
from metabolic diseases and aging-associated pathologies.
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